Ion Beam (IBAB) | Stock Overview & Key Data

Ion Beam Applications S.A. | Mid-cap | Healthcare

€12.00

-1.80%

| Ion Beam Stock Comparison:

Ion Beam vs Sequana Medical NV Ion Beam vs Argenx SE Ion Beam vs Solvac S.A Ion Beam vs Fagron NV Ion Beam vs Nyxoah S.A Ion Beam vs BEL 20 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Ion Beam Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €11.96 High: €12.38

on June 17, 2025

52 Week Range

Low: €9.40 High: €15.14

on April 7, 2025

on October 11, 2024

All-Time High: €56.94 on May 8, 2017

Explore how other BE stocks compare to their 52-week ranges: View BE Market 52-Week Insights

Key Statistics

Market Cap i €363.5M

EPS i 0.31

P/E Ratio (TTM) i 39.42

Forward P/E i 12.22

P/B Ratio i 3.23

PEG Ratio i 12.22

Div. Yield i 1.96%

ROE i 8.52%

Beta i 1.007

Debt to Equity i 39.39

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 10.65%

Profit Margin i 1.86%

Returns and Earnings

Return on Assets (TTM) i 2.89%

Return on Equity (TTM) i 8.52%

EBITDA i €24.2M

Net Income (TTM) i €9.3M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i €0.17

Estimated Dividend Yield i 1.39%

5 Year Average Dividend Yield i 1.25%

Last 12-Month Dividend Yield i 1.96%

Last 12-Month Dividend i €0.24

% of Earnings Paid as Dividends i 54.17%

Dividend Date i N/A

Ex-Dividend Date i June 27, 2024

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Ion Beam IBAB	363.48M Mid-cap	-3.69%	5.45%	-6.25%	-8.95%	-12.02%	-8.53%	-17.43%	55.67%
Sequana Medical NV SEQUA	57.44M Small-cap	7.29%	1.98%	-35.22%	41.10%	-57.96%	-32.43%	-80.31%	-84.57%
Argenx SE ARGX	30.72B Large-cap	-5.90%	-4.22%	-13.76%	-20.25%	-20.91%	39.26%	51.84%	157.48%
Solvac S.A SOLV	1.87B Large-cap	0.00%	1.14%	-7.87%	-13.17%	-10.28%	-20.55%	-7.02%	-8.19%
Fagron NV FAGR	1.60B Large-cap	-0.23%	2.58%	13.92%	18.88%	30.37%	23.59%	35.27%	12.31%
Nyxoah S.A NYXH	252.65M Mid-cap	-2.87%	18.56%	-30.21%	-12.76%	-21.28%	-7.79%	-36.92%	-65.38%

Ownership & Short Interest

Insider Ownership i 34.63%

Institutional Ownership i 25.71%

Shares Short i N/A

Short Ratio i N/A

Short % of Shares Outstanding i N/A

Average 10-Day Volume i 18K

Average 90-Day Volume i 32K

Ion Beam Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Ion Beam would have performed over time.

Investment Amount

€

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is IBAB's 52-week high and low?

In the last 52 weeks, Ion Beam reached a high of €15.14 (on October 11, 2024) and a low of €9.40 (on April 7, 2025).

What is the market cap and P/E ratio for IBAB?

Curious about Ion Beam's size and valuation? Its market capitalization stands at 363.48M. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.42, and the forward P/E (looking ahead) is 12.22.

Does IBAB pay dividends? If so, what's the yield?

Yes, Ion Beam is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.96%, and the company is expected to pay out €0.17 per share over the coming year.

Who are Ion Beam's main competitors or similar companies to consider before investing?

When looking at Ion Beam, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Sequana Medical NV SEQUA	57.44M	Healthcare	Medical Devices	-32.43%	-80.31%
Argenx SE ARGX	30.72B	Healthcare	Biotechnology	39.26%	51.84%
Solvac S.A SOLV	1.87B	Healthcare	Medical Instruments & Supplies	-20.55%	-7.02%
Fagron NV FAGR	1.60B	Healthcare	Drug Manufacturers - Specialty & Generic	23.59%	35.27%
Nyxoah S.A NYXH	252.65M	Healthcare	Medical Instruments & Supplies	-7.79%	-36.92%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Ion Beam Applications S.A.? (e.g., ROE, Debt/Equity)

To get a sense of Ion Beam's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.52%, the Debt to Equity ratio from the most recent quarter is 39.39, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for IBAB?

Looking at Ion Beam's growth, its revenue over the trailing twelve months (TTM) was €498M. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.90%, and quarterly earnings saw a YoY growth of 7.70%.

How much of IBAB stock is held by insiders and institutions?

Wondering who owns Ion Beam stock? Company insiders (like executives and directors) hold about 34.63% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 25.71%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.